We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
-20.55%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
AUM
$761M
AUM Growth
+$324M
Cap. Flow
+$462M
Cap. Flow %
60.75%
Top 10 Hldgs %
9.83%
Holding
1,302
New
602
Increased
163
Reduced
60
Closed
477

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$15.9M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$9.6M
3
HCA icon
HCA Healthcare
HCA
+$8.15M
4
COP icon
ConocoPhillips
COP
+$8.08M
5
ILMN icon
Illumina
ILMN
+$7.69M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$7.5M
2
O icon
Realty Income
O
+$4.54M
3
ZBH icon
Zimmer Biomet
ZBH
+$4.2M
4
AAL icon
American Airlines Group
AAL
+$4.17M
5
DOW icon
Dow Inc
DOW
+$3.63M

Sector Composition

Rank Sector Weight
1 Technology 16.21%
2 Consumer Discretionary 13.41%
3 Financials 12.51%
4 Industrials 11.01%
5 Healthcare 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSTM icon
776
Verastem
VSTM
$516M
$30K ﹤0.01%
+2,136
New +$34K
DHC
777
Diversified Healthcare Trust
DHC
$2.19B
$29K ﹤0.01%
+16,088
New +$36.8K
VHC icon
778
VirnetX Holding Corp
VHC
$52.7M
$29K ﹤0.01%
+1,222
New +$34K
INFI
779
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$26K ﹤0.01%
+41,396
New +$31.8K
ARAY icon
780
Accuray
ARAY
$28.2M
$25K ﹤0.01%
+12,955
New +$32.3K
LVO icon
781
LiveOne
LVO
$62.9M
$25K ﹤0.01%
+2,879
New +$23.6K
CARM
782
DELISTED
Carisma Therapeutics
CARM
$24K ﹤0.01%
+1,504
New +$17.2K
FBIO icon
783
Fortress Biotech
FBIO
$112M
$24K ﹤0.01%
+1,891
New +$28K
IMDX
784
Insight Molecular Diagnostics
IMDX
$147M
$24K ﹤0.01%
+1,350
New +$30.7K
SPRU icon
785
Spruce Power Holding Corp
SPRU
$37.7M
$22K ﹤0.01%
+2,358
New +$27.2K
FLNT
786
Fluent
FLNT
$107M
$21K ﹤0.01%
+2,998
New +$25K
LAB icon
787
Standard BioTools
LAB
$323M
$21K ﹤0.01%
+13,132
New +$32.5K
VRM icon
788
Vroom Inc
VRM
$37.5M
$21K ﹤0.01%
+213
New +$26.7K
CMRX
789
DELISTED
Chimerix, Inc.
CMRX
$21K ﹤0.01%
+10,072
New +$32.3K
SPPI
790
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$21K ﹤0.01%
+26,513
New +$23.4K
CLVS
791
DELISTED
Clovis Oncology, Inc.
CLVS
$21K ﹤0.01%
+11,630
New +$17.2K
ATOS icon
792
Atossa Therapeutics
ATOS
$23.2M
$18K ﹤0.01%
+1,127
New +$17.8K
RNAC icon
793
Cartesian Therapeutics
RNAC
$225M
$18K ﹤0.01%
+451
New +$13.4K
DS
794
DELISTED
Drive Shack Inc.
DS
$18K ﹤0.01%
+12,837
New +$18.3K
AWH
795
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$17K ﹤0.01%
+1,898
New +$19.3K
ZY
796
DELISTED
Zymergen Inc. Common Stock
ZY
$17K ﹤0.01%
+13,944
New +$23.4K
NBEV
797
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$17K ﹤0.01%
+76,909
New +$29K
CTXR icon
798
Citius Pharmaceuticals
CTXR
$13.9M
$16K ﹤0.01%
+694
New +$19K
EPZM
799
DELISTED
Epizyme, Inc
EPZM
$16K ﹤0.01%
+10,697
New +$7.86K
ADVM
800
DELISTED
Adverum Biotechnologies
ADVM
$14K ﹤0.01%
+1,130
New +$11.8K

Similar funds

Y-Intercept (HK)'s Q2 2022 Portfolio in Review

As of Q2 2022, Y-Intercept (HK) held 1,302 positions worth $761M, up 74% from $437M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Y-Intercept (HK) deployed $462M of net new capital in Q2 2022, opening 602 new positions and adding to 163 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 30,610 shares worth $8.36M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was CenterPoint Energy, an estimated $1.92M trimmed.

  • Y-Intercept (HK)'s largest Q2 2022 buy was Berkshire Hathaway Class B: 30,610 shares worth $8.36M.
  • Y-Intercept (HK) added most to Apple in Q2 2022, an estimated $15.9M increase.
  • Y-Intercept (HK)'s biggest Q2 2022 reduction was CenterPoint Energy, cutting an estimated $1.92M.
  • Y-Intercept (HK) fully exited Linde in Q2 2022, selling an estimated $7.5M.
  • Y-Intercept (HK)'s ten largest holdings make up 9.8% of its $761M portfolio in Q2 2022.
  • Y-Intercept (HK) opened 602 new positions and closed 477 in Q2 2022.
  • Y-Intercept (HK)'s portfolio value rose 74% quarter-over-quarter to $761M.

Based on Y-Intercept (HK)'s 13F filing for Q2 2022, filed 8 Aug 2022.